| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $148.6M | +49.1% |
| Cost of Revenue | $55.9M | +28.4% |
| R&D Expense | $4.7M | +129.7% |
| SG&A Expense | $141.8M | +26.6% |
| Operating Income | -$65.3M | -47.1% |
| Interest Expense | $9.1M | +551.6% |
| Pre-tax Income | -$74.3M | -58.9% |
| Income Tax | $95K | +126.2% |
| Net Income | -$74.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $53.9M | -63.1% |
| Accounts Receivable | $22.4M | +53.2% |
| Inventory | $18.9M | +969.9% |
| Current Assets | $100.8M | -43.6% |
| Total Assets | $178.0M | -30.9% |
| Current Liabilities | $46.5M | -19.3% |
| Long-term Debt | $71.9M | +0.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$84.9M | -154.3% |
| Capital Expenditures | $1.6M | +311.7% |
| Investing Cash Flow | -$2.9M | -172.9% |
| Financing Cash Flow | -$4.1M | -105.7% |
| Free Cash Flow | -$86.5M | -156.1% |
| -59.0% |
| EPS (Basic) | -$1.33 | -41.5% |
| EPS (Diluted) | -$1.33 | -41.5% |
| Total Liabilities |
| $159.5M |
| -9.2% |
| Stockholders' Equity | $18.5M | -77.4% |